Turmeric supplement‐associated hepatitis: a clinicopathological series of 11 cases highlighting pan‐lobular and zone 3 injury

David J Papke,Kathleen Viveiros,Victor Zota,Ryan M Gill,Iván A González,Joseph Misdraji,Deepa T Patil
DOI: https://doi.org/10.1111/his.15333
2024-10-11
Histopathology
Abstract:We describe 11 cases of turmeric supplement‐associated liver injury. Biopsies showed acute hepatitis (eight patients; five pan‐lobular, three zone 3‐predominant), scattered histiocytic aggregates (two patients) and chronic hepatitis (one patient). When investigating aetiologies for liver injury, consideration should be given to supplements purportedly containing innocuous compounds such as turmeric. Aims Although turmeric is commonly ingested and well tolerated, there is increasing evidence that over‐the‐counter turmeric supplements can cause drug‐induced liver injury. We sought to thoroughly characterise clinicopathological features of patients for whom liver injury was attributed clinically to turmeric supplements. Methods and results We identified 11 patients via retrospective pathology archive review: 10 females (91%) and one male, with a median age of 58 years (range = 37–66 years). Six patients (55%) were asymptomatic with abnormal liver function tests, while five patients (45%) presented with malaise and/or jaundice. Ten patients (91%) showed predominant transaminase abnormalities, while one exhibited predominant alkaline phosphatase elevation. Histologically, biopsies showed acute hepatitis (eight cases, 73%, including five pan‐lobular and three zone 3‐predominant inflammation), scattered lobular aggregates of histiocytes (two; 18%) and a chronic hepatitis pattern of injury (one; 9%). Mild bile duct injury was present in five biopsies (45%). All patients stopped ingesting turmeric supplements after presenting with liver injury, and four patients additionally received steroid therapy; liver function tests normalised in all patients. Roussel Uclaf causality assessment method (RUCAM) analysis estimated the likelihood of turmeric supplement‐associated liver injury to be probable (eight cases) and possible (three). Conclusions Histological features in the 'possible' cases were consistent with drug‐induced injury, highlighting the added benefit of histological analysis relative to RUCAM analysis isolation. This study underscores the need to obtain a full history of over‐the‐counter medications and supplements when investigating aetiologies for liver injury, including supplements purportedly containing innocuous compounds such as turmeric.
pathology,cell biology
What problem does this paper attempt to address?